Total Payments
$2,928
2024 Payments
$611.36
Companies
36
Transactions
187
Medicare Patients
914
Medicare Billing
$84,958

Payment Breakdown by Category

Food & Beverage$2,922 (99.8%)
Education$5.90 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,922 186 99.8%
Education $5.90 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $362.21 22 $0 (2024)
ABBVIE INC. $259.14 18 $0 (2024)
Amarin Pharma Inc. $229.21 13 $0 (2022)
GlaxoSmithKline, LLC. $201.49 11 $0 (2024)
Abbott Laboratories $193.64 10 $0 (2024)
AstraZeneca Pharmaceuticals LP $181.81 14 $0 (2024)
Lilly USA, LLC $171.47 12 $0 (2024)
PFIZER INC. $146.05 8 $0 (2024)
Astellas Pharma US Inc $124.73 8 $0 (2024)
Novo Nordisk Inc $114.99 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $611.36 36 Novo Nordisk Inc ($72.78)
2023 $521.75 30 PFIZER INC. ($74.44)
2022 $609.79 36 Boehringer Ingelheim Pharmaceuticals, Inc. ($145.81)
2021 $228.71 14 Biohaven Pharmaceuticals, Inc. ($30.62)
2020 $150.58 11 AstraZeneca Pharmaceuticals LP ($37.29)
2019 $490.39 35 Amarin Pharma Inc. ($137.11)
2018 $303.34 24 Amgen Inc. ($37.29)
2017 $11.62 1 Valeant Pharmaceuticals North America LLC ($11.62)

All Payment Transactions

187 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/24/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $19.46 General
Category: Diabetes Care
12/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $14.27 General
Category: NEUROSCIENCE
11/19/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.13 General
Category: Diabetes
11/04/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $16.94 General
Category: PAIN
11/04/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $16.11 General
Category: VILOXAZINE HYDROCHLORIDE
10/29/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $17.51 General
Category: DIABETES
10/24/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.26 General
Category: Cardio-renal
10/15/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.58 General
Category: Respiratory
10/10/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $24.95 General
Category: RESPIRATORY
09/26/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $16.77 General
Category: Diabetes Care
09/25/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $16.37 General
Category: Endocrinology
09/04/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $15.93 General
Category: Diabetes
08/30/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $14.15 General
Category: Diabetes
08/14/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $16.94 General
Category: PAIN
07/16/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $14.47 General
Category: Respiratory
06/12/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.28 General
Category: Diabetes
05/29/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.97 General
Category: Diabetes
05/28/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.43 General
Category: NEUROSCIENCE
05/16/2024 Abbott Laboratories FREESTYLE LIBRE 3 (Device) Food and Beverage In-kind items and services $16.67 General
Category: Diabetes Care
05/14/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological) Food and Beverage In-kind items and services $14.56 General
Category: VACCINES
05/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $17.72 General
Category: DIABETES
04/24/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $15.98 General
Category: Cardio-renal
04/16/2024 PFIZER INC. NURTEC ODT (Drug) Food and Beverage In-kind items and services $18.13 General
Category: PAIN
04/11/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $13.97 General
Category: Respiratory
04/03/2024 Hikma Pharmaceuticals USA Ryaltris (Drug) Food and Beverage In-kind items and services $14.84 General
Category: Pulmonary/Respiratory Diseases

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 244 402 $108,106 $25,686
2022 6 251 382 $93,562 $22,566
2021 4 216 353 $90,579 $20,990
2020 5 203 302 $77,750 $15,716
Total Patients
914
Total Services
1,439
Medicare Billing
$84,958
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 140 261 $84,303 $18,885 22.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 57 76 $16,568 $4,420 26.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 15 15 $5,085 $1,905 37.5%
83036 Hemoglobin a1c level Office 2023 32 50 $2,150 $476.00 22.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 121 212 $68,476 $15,387 22.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 52 68 $14,824 $4,016 27.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 11 11 $3,729 $1,434 38.4%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 21 25 $3,275 $895.03 27.3%
83036 Hemoglobin a1c level Office 2022 34 54 $2,322 $507.82 21.9%
71046 X-ray of chest, 2 views Office 2022 12 12 $936.00 $326.03 34.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 121 218 $70,414 $15,854 22.5%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 50 72 $15,696 $4,008 25.5%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 19 20 $2,620 $720.80 27.5%
83036 Hemoglobin a1c level Office 2021 26 43 $1,849 $407.82 22.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 97 166 $53,618 $10,506 19.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 69 99 $21,582 $4,121 19.1%
90662 Vaccine for influenza for injection into muscle Office 2020 11 11 $990.00 $670.78 67.8%
G0009 Administration of pneumococcal vaccine Office 2020 15 15 $900.00 $234.36 26.0%
G0008 Administration of influenza virus vaccine Office 2020 11 11 $660.00 $184.14 27.9%

About Dr. John Zarosky, MD

Dr. John Zarosky, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568626646.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Zarosky, MD has received a total of $2,928 in payments from pharmaceutical and medical device companies, with $611.36 received in 2024. These payments were reported across 187 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,922).

As a Medicare-enrolled provider, Zarosky has provided services to 914 Medicare beneficiaries, totaling 1,439 services with total Medicare billing of $84,958. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

Products in Payments

  • NURTEC ODT (Drug) $269.78
  • JARDIANCE (Drug) $259.23
  • Vascepa (Drug) $229.21
  • UBRELVY (Drug) $127.99
  • FARXIGA (Drug) $124.94
  • MOUNJARO (Drug) $124.44
  • FREESTYLE LIBRE 3 (Device) $108.97
  • TRELEGY ELLIPTA (Drug) $106.61
  • Kerendia (Drug) $88.04
  • Ozempic (Drug) $67.71
  • VRAYLAR (Drug) $65.97
  • FREESTYLE LIBRE 2 (Device) $61.73
  • Myrbetriq (Drug) $58.63
  • JANUVIA (Drug) $58.62
  • STIOLTO RESPIMAT (Drug) $50.94
  • QULIPTA (Drug) $48.24
  • Veozah (Drug) $46.74
  • SHINGRIX (Biological) $45.67
  • SPIRIVA RESPIMAT (Drug) $45.32
  • Dexcom G6 Transmitter (Medical Supply) $45.15

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bedford